CHRISTINA LAKE CANNABIS Asset Resilience Ratio
CHRISTINA LAKE CANNABIS asset resilience ratio. CHRISTINA LAKE CANNABIS (CLB) has an Asset Resilience Ratio of 0.27% as of May 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CHRISTINA LAKE CANNABIS (CLB) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of CHRISTINA LAKE CANNABIS (2021–2025)
Asset resilience ratio of CHRISTINA LAKE CANNABIS from 2021 to 2025. This chart shows how CHRISTINA LAKE CANNABIS's Asset Resilience Ratio has changed over time. See CHRISTINA LAKE CANNABIS free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down CHRISTINA LAKE CANNABIS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CLB total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €52.67K | 0.27% |
| Total Liquid Assets | €52.67K | 0.27% |
Asset Resilience Insights
- Limited Liquidity: CHRISTINA LAKE CANNABIS maintains only 0.27% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CHRISTINA LAKE CANNABIS Industry Peers by Asset Resilience Ratio
Compare CHRISTINA LAKE CANNABIS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Abbott India Limited
NSE:ABBOTINDIA |
Drug Manufacturers - Specialty & Generic | 53.22% |
|
Shenzhen Salubris Pharmaceuticals Co Ltd
SHE:002294 |
Drug Manufacturers - Specialty & Generic | 4.97% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Shanxi Zhendong Pharmaceutical
SHE:300158 |
Drug Manufacturers - Specialty & Generic | 10.74% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
CHRISTINA LAKE CANNABIS Asset Resilience Ratio by Year (2021–2025)
CHRISTINA LAKE CANNABIS asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for CHRISTINA LAKE CANNABIS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-11-30 | 0.26% | €52.67K ≈ $61.57K |
€20.35 Million ≈ $23.80 Million |
+0.04pp |
| 2024-11-30 | 0.21% | €50.00K ≈ $58.46K |
€23.37 Million ≈ $27.32 Million |
-- |
| 2023-11-30 | 0.00% | €0.00 ≈ $0.00 |
€15.96 Million ≈ $18.66 Million |
-- |
| 2022-11-30 | 0.15% | €28.75K ≈ $33.61K |
€18.79 Million ≈ $21.97 Million |
+0.00pp |
| 2021-11-30 | 0.15% | €28.75K ≈ $33.61K |
€19.04 Million ≈ $22.26 Million |
-- |
About CHRISTINA LAKE CANNABIS
Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It provides distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christ… Read more